Pfizer’s Science Will Win Podcast – Season 4

About Project

Pfizer’s Science Will Win podcast takes listeners under the microscope on some of the most promising medical innovations, exploring therapies which have the potential to shape the future of healthcare and offer new hope to patients around the world. Through conversations with a diverse line-up of guests, including scientists and experts, patient advocates and, most importantly, patients themselves, each mini-series focuses on a unique healthcare challenge, diving into the fascinating science, policy challenges and potential to transform patients’ lives for the better.
Season 4 of Science Will Win tackles the question: What challenges did science have to overcome to bring us where we are today, in the midst of an AI revolution in medicine? Artificial intelligence has the potential to help save millions of lives by accelerating the discovery and development of treatments for humanity’s toughest diseases. Those AI innovations come down to three key factors: data, hardware, and software. This season takes listeners on a journey back in time to learn how each of these three elements got where it is today.
Science Will Win is hosted by tech investor and AI thought leader Jeremiah Owyang, who is currently a general partner at Blitzscaling Ventures and is frequently quoted in outlets like The New Yorker, Forbes, and Fast Company. And each episode features interviews with historians and cutting-edge researchers, framing these deep historical dives within modern advancements in medical technology. From the historical serendipity of medical breakthroughs to today’s data-driven landscape, they delve into the rise of "omics" and single-cell sequencing, the critical role of computational resources, and the evolution of AI-powered software. Through insightful conversations guided by host Jeremiah Owyang, the season reveals how these innovations are revolutionizing drug development and offers a glimpse into the exciting possibilities ahead in the quest for new medicines.
We targeted the general public, science enthusiasts, healthcare professionals, and techies, and crafted episodes using creative sound design and narrative storytelling. Cold opens immersed listeners in the historical context of each episode, setting the stage for deeper exploration (from highlighting the human genome to how video game software helped pave the way for AI in medicine and beyond).
In addition to distributing on all podcast platforms and the Pfizer website, the content for this series was amplified via paid and organic tactics including social, digital and print channels to reach the general public.
Science Will Win hit over 1 million downloads with this latest season, marking a huge milestone for the podcast. And promotion of the podcast’s fourth season resulted in a 30% increase in average downloads per episode from the previous season. These strong results were a combination of paid media, activating a multi-channel amplification approach and leveraged research and insights to guide our strategy and channel usage.
Season 4 of Science Will Win debuted in the top 1% of podcasts globally. As of March 2025, SWW had broken into the top 10 on the Apple Podcasts: United States of America: Life Sciences chart. It also topped the science charts around the world, including Great Britain, Spain, India, Ireland, Greece, and many more.